Daniel R. Chevallard Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daniel R. Chevallard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel R. Chevallard. Daniel R. Chevallard is a CFO and COO in Viracta Therapeutics, Inc. ($SNSS) and a Chief Financial Officer in Regulus Therapeutics Inc. ($RGLS).
Address: C/O REGULUS THERAPEUTICS INC. 10614 SCIENCE CENTER DR. SAN DIEGO 92121 CA
Companies in which Daniel R. Chevallard is an Insider
Regulus Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daniel R. Chevallard: Chief Financial Officer
Holdings: 77,870 shares
Current Value: $109,018
Latest Transaction: Jul 02 2019
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viracta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daniel R. Chevallard: CFO and COO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 30 2021
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Daniel R. Chevallard
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | SNSS | Viracta Therapeuti ... | Chevallard Daniel R. | CFO and COO | Option Exercise | A | 8.74 | 78,912 | 689,691 | 78,912 | |
| Jul 02 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Sell | S | 1.31 | 2,669 | 3,500 | 77,870 | 80.5 K to 77.9 K (-3.31 %) |
| May 16 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 0.95 | 8,000 | 7,600 | 7,500 | |
| May 16 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Sell | S | 1.41 | 10,000 | 14,089 | 80,539 | 90.5 K to 80.5 K (-11.04 %) |
| May 16 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Grant | A | 0.00 | 55,414 | 0 | 90,539 | 35.1 K to 90.5 K (+157.76 %) |
| Apr 03 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Sell | S | 0.98 | 3,253 | 3,192 | 9,372 | 12.6 K to 9.4 K (-25.77 %) |
| Feb 06 2019 | RGLS | Regulus Therapeuti ... | Chevallard Daniel R. | Chief Financial Off ... | Option Exercise | A | 0.95 | 30,000 | 28,500 | 30,000 |